Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Alzheimer’s disease

Study reveals AI insights can predict development of disease a decade in advance

Study reveals AI insights can predict development of disease a decade in advance
p p Read More

The study predicted the development of conditions including Alzheimer’s and heart disease

August 8, 2024 Alzheimer's disease, artificial intelligence, heart disease, News, Optima Partners, type 2 diabetes, University of Edinburgh

MIT study reveals how specific cells in AD become vulnerable and resilient

MIT study reveals how specific cells in AD become vulnerable and resilient
p p Read More

The neurodegenerative condition is recognised as the most common form of dementia

July 29, 2024 Alzheimer's disease, Dementia, Massachusetts Institute of Technology, neurodegenerative diseases, News, reelin, Religious Order Study, Rush Memory and Aging Project

Study suggests targeting amyloid beta production could be promising in AD

Study suggests targeting amyloid beta production could be promising in AD
p p Read More

The neurodegenerative disease is currently the most common cause of dementia

July 24, 2024 Alzheimer's disease, amyloid-beta, News, oligodendrocytes, UK Dementia Research Institute, University College London

Researchers reveal how a protein interaction can increase Alzheimer’s risk

Researchers reveal how a protein interaction can increase Alzheimer’s risk
p p Read More

AD is the most common form of dementia, which affects over 944,000 people in the UK

June 26, 2024 Alzheimer's disease, amyloid-beta, APOE4, Dementia, neurodgenerative diseases, News, Sheffield Institute of Translational Neuroscience, UK Dementia Research Institute, university of sheffield

New study reveals how brain cell communication is linked to Alzheimer’s disease

New study reveals how brain cell communication is linked to Alzheimer’s disease
p p Read More

Two support cells, microglia and astrocytes, were found to communicate with each other

June 12, 2024 Alzheimer's disease, astrocytes, Francis Crick Institute, microglia, neurodegenerative conditions, News, UCL UK Dementia Research Institute, VIB-KU Leuven Center for Brain and Disease Research

LucyTx announces additional $12.5m research funding for neurological diseases

LucyTx announces additional .5m research funding for neurological diseases
p p Read More

Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally

June 11, 2024 Alzheimer's disease, Bill & Melinda Gates Foundation, Lucy Therapeutics, Michael J. Fox Foundation, neurological conditions, News, Parkinson's disease, Parkinson’s UK, Rett syndrome, Safar Partners

UCL study to assess link between navigation and AD using virtual reality

The progressive neurodegenerative condition is the most common form of dementia

April 24, 2024 Alzheimer's disease, Join Dementia Research, News, University College London, virtual reality, Virtual Reality Navigation

Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants

The progressive neurodegenerative disease is estimated to affect 24 million people globally

April 3, 2024 Alzheimer's disease, amyloid, amyloid precursor protein, bone marrow transplants, Dementia, neurodegenerative diseases, News, University of British Columbia

Roche partners with Cardiff researchers to uncover new research into dementia

Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions

March 14, 2024 Alzheimer's disease, Cardiff University Brain Research Imaging Centre, Dementia, neurodegenerative conditions, News, Parkinson's disease, roche

Poor spatial navigation could predict Alzheimer’s before symptom onset

Around 900,000 people in the UK are affected by the progressive neurodegenerative disease

March 4, 2024 Alzheimer's disease, News, spatial navigation, University College London, University of Cambridge, virtual reality

Posts navigation

« Previous

Posts pagination

1 2 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy